• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • EMBELIN
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • AMPK
      • ANTI AGING
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • EPIGENETIC MODIFIERS
      • EXCITOXICITY & THE BRAIN
      • FGF21
      • FLAVONES
      • GLUTAMATE & BRAIN
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HORMESIS
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • IKK
      • IL-6/STAT3
      • IRISIN
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MITOCHONDRIAL UNCOUPLING
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL AROMATASE INHIBITORS
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
      • TRAUMATIC BRAIN INJURY (HEALING)
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    OXYTOCIN
    February 19, 2021
    IRISIN
    February 19, 2021
    1. A boost in mitochondrial activity underpins the cholesterol–lowering effect of annurca apple polyphenols on hepatic cells
    2. A Case of Acquired Ichthyosis Developed During cholesterol–lowering Treatment
    3. A chalcone derivative, 1m‐6, exhibits atheroprotective effects by increasing cholesterol efflux and reducing inflammation‐induced endothelial dysfunction
    4. A chicken protein hydrolysate exerts anti‐atherosclerotic effect beyond plasma cholesterol‐lowering activity in Apoe−/− mice
    5. A cholesterol reducing diet is not useful
    6. A cholesterol–lowering diet does not produce adverse psychological effects in children: three-year results from the dietary intervention study in children.
    7. A cholesterol–lowering gene maps to chromosome 13q
    8. A cholesterol–lowering VLP vaccine that targets PCSK9
    9. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation
    10. A comparison of clinical outcome studies among cholesterol–lowering agents
    11. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: results of a meta-analysis of randomized …
    12. A Contemporary Assessment of Lipid lowering Therapies and Low-density Lipoprotein cholesterol in Peripheral Artery Disease
    13. A High cholesterol-reducing Lactic Acid Bacterial Strain: Screening, Identification and Probiotic Potential Evaluation
    14. A Intervention Study on cholesterol–lowering Effect of Phytosterol Ester
    15. A koleszterincsökkentés nem a Szent Grál, de nem is az ördög műve= cholesterol–lowering is not the Holy Grail, but neither is the work of the devil
    16. A laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary care
    17. A Lipid-lowering diet Combined with Exercise is Effective for Achieving Healthy Serum cholesterol in a Male with a Predisposition for Developing Hyperlipidemia …
    18. A lipidomic analysis approach to evaluate the response to cholesterol–lowering food intake
    19. A long-term population study of cholesterol lowering by sitostanol ester margarine
    20. A mechanism for the action of unsaturated fat in reducing the serum cholesterol.
    21. A mechanistic systems pharmacology model for prediction of LDL cholesterol lowering by PCSK9 antagonism in human dyslipidemic populations
    22. A Mendelian Randomization Analysis Of Lipoprotein (A) lowering And Cardiovascular Risk Stratified By Ldl cholesterol, Gender, And Antiplatelet Therapy …
    23. A mini-review of human studies on cholesterol–lowering properties of probiotics
    24. A model for evaluating the cost-effectiveness of cholesterol–lowering treatment
    25. A Model of Life Extension from Reducing Serum cholesterol
    26. A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol–lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin …
    27. A multidisciplinary study of the bioavilability and cholesterol–lowering property of peptides from lupin protein
    28. A nano‐emulsion of lutein is more effective than regular lutein in reducing cholesterol‐induced liver injury in guinea pigs
    29. A national program for lowering high blood cholesterol
    30. A new feature on the cholesterol–lowering landscape
    31. A New Perspective on the Development of cholesterol–lowering Products
    32. A new reality: achieving cholesterol–lowering goals in clinical practice
    33. A pediatrician attends the National Institutes of Health Consensus Conference on lowering blood cholesterol
    34. A pharmacoeconomic evaluation of aggressive cholesterol lowering in Sweden
    35. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive cholesterol lowering (MIRACL) study in the United Kingdom
    36. A pharmacoeconomic evaluation of the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study in Canada
    37. A PHARMACOECONOMIC REVIEW OF cholesterol–lowering THERAPY INTERVENTIONS.
    38. A phase 1 study to evaluate the safety and LDL cholesterol–lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin …
    39. A pilot randomized controlled clinical trial to assess tolerance and efficacy of navy bean and rice bran supplementation for lowering cholesterol in children
    40. A pilot study to assess food safety and potential cholesterol–lowering efficacy of Antrodia cinnamomea solid-state cultivated mycelium in healthy adults
    41. A promoter polymorphism in cholesterol 7α-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin
    42. A pulse-based diet is effective for reducing total and LDL-cholesterol in older adults
    43. A Quantitative Systems Pharmacology PhysioPDTM Platform to Investigate the Impact of cholesterol–lowering Therapies on Lipid Profiles and Plaque …
    44. A quantitative systems pharmacology platform to investigate the impact of alirocumab and cholesterol–lowering therapies on lipid profiles and plaque characteristics
    45. A randomized clinical trial evaluating a proprietary mixture of Lactobacillus plantarum strains for lowering cholesterol 1
    46. A randomized crossover study to evaluate LDL-cholesterol lowering effect of a generic product of simvastatin (Unison company) compared to simvastatin (Zocor) in …
    47. A randomized, double-blind, placebo-controlled trial investigating cholesterol–lowering effects and safety of yellow yeast rice in adults with mild to moderate …
    48. A randomized, placebo-controlled, double-blind crossover study to assess a unique phytosterol ester formulation in lowering LDL cholesterol utilizing a novel virtual …
    49. A rational policy for measuring and lowering cholesterol
    50. A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control
    51. A review of available cholesterol–lowering medicines in South Africa
    52. A ruthenium derivative of quercetin with enhanced cholesterol–lowering activity
    53. A spread containing bioactive milk peptides Ile–Pro–Pro and Val–Pro–Pro, and plant sterols has antihypertensive and cholesterol–lowering effects
    54. A study of lactobacillus acidophilus as a cholesterol lowering agent in hypercholesterolemic individuals.
    55. A STUDY ON cholesterol lowering EFFECT OF PLEUROTUS SAJOR-CAJU MUSHROOM IN HYPERcholesterolEMIC RATS
    56. A study on screening of cholesterol–lowering lactic acid bacteria
    57. A survey of cholesterol lowering therapies and achievement of targets for cardiovascular prevention in type 2 diabetes in Italy
    58. A sustainable approach for the extraction of cholesterol–lowering compounds from an olive by-product based on CO 2-expanded ethyl acetate
    59. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
    60. A test of two educational strategies for lowering blood cholesterol at the worksite
    61. A Transcriptomics-Informed Genetic Association Study Identifies RHOA in Simvastatin-Induced Low-Density Lipoprotein cholesterol lowering
    62. A9125 Major Outcomes of Blood-pressure and cholesterol lowering in High-risk Hypertensive Patients with a High–normal Level of Total cholesterol
    63. Ability of Lactobacillus plantarum JR64 isolated from noni juice in lowering cholesterol in vivo
    64. Absolute benefit from cholesterol lowering in diabetic patients with coronary heart disease
    65. Abstract P088: The cholesterol–lowering Effect of Phytosterols across Different Dose Ranges: A Meta-analysis of Randomized Controlled Trials
    66. Acalypha Indica and Gemfibrozil lowering cholesterol and Triglyceride Levels in High Fructose-cholesterol diet Induced Rats
    67. ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol–lowering and direct effects in apolipoprotein E-deficient mice
    68. ACAT inhibitors: the search for novel cholesterol lowering agents
    69. Achievement of LDL-cholesterol target levels and other cardiovascular risk factor targets in patients with type 2 diabetes treated with lipid-lowering medications …
    70. Acquired lecithin: cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease
    71. Activation of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducing cholesterol efflux from human …
    72. Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels
    73. Activity of a streptococcal cholesterol–lowering protein vs. hdl from apo ai-deficient mice in vitro and in vivo
    74. Activity of psyllium hydrophilic colloid for reducing serum cholesterol in sea quail fed a diet supplemented with cholesterol.
    75. Activity of Sambiloto Extract (Andrographis paniculata Ness) in Reducing Total Blood cholesterol Levels Hypercholesterolemia Rats
    76. Activity Test of Suji Leaf Extract (Dracaena angustifolia Roxb.) on in vitro cholesterol lowering
    77. Acute cholesterol lowering with LDL-apheresis improves endothelial function of the epicardial coronary artery in patients with hypercholesterolemia
    78. Acyl-CoA: cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol–lowering effect in ApoE* 3-Leiden mice
    79. Adding monounsaturated fatty acids to a dietary portfolio of cholesterol–lowering foods in hypercholesterolemia
    80. Adding MUFA to a dietary portfolio of cholesterol–lowering foods reduces apoAI fractional catabolic rate in subjects with dyslipidaemia
    81. Additive effect of homocysteine‐and cholesterol‐lowering therapy on endothelium‐dependent vasodilation in patients with cardiovascular disease
    82. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia
    83. Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and …
    84. Adherence to cholesterol–lowering diets
    85. AdipoRon Attenuates Wnt Signaling by Reducing cholesterol-Dependent Plasma Membrane Rigidity
    86. Advance in cholesterol–lowering effect of phytosterols [J]
    87. Advances in cholesterol–lowering interventions
    88. Advances in techniques for reducing cholesterol in egg yolk: A review
    89. Advances in the effects study of the cholesterol-reducing microbial [J]
    90. Aerobic exercise training selectively changes oxysterol levels and metabolism reducing cholesterol accumulation in the aorta of dyslipidemic mice
    91. After ENHANCE: is more LDL cholesterol lowering even better?
    92. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors: NHLBI post coronary …
    93. Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)
    94. Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation
    95. Air Force Members’ Guide for Reducing cholesterol Ratio
    96. Algal sterols are as effective as β-sitosterol in reducing plasma cholesterol concentration
    97. Alirocumab for low-density lipoprotein cholesterol lowering
    98. All cholesterol–lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT
    99. Aloe-emodin exerts cholesterol–lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats
    100. Alternative approaches to cholesterol–lowering therapy
    101. Alternative approaches to lowering cholesterol
    102. Amaranth oil increased fecal excretion of bile acid but had no effect in reducing plasma cholesterol in hamsters
    103. Amaranth protein presents cholesterol–lowering effect
    104. AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol
    105. An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol
    106. An application of the transtheoretical model of behavior change to the adoption of cholesterol–lowering behaviors by college students.
    107. An audit of secondary prevention of ischaemic heart disease using aspirin and cholesterol–lowering
    108. An audit of the effectiveness of PCSK9 inhibition in reducing cholesterol in patients attending lipid clinics
    109. An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction
    110. An educational intervention for reducing the intake of dietary fats and cholesterol among middle-aged and older women
    111. An Evaluation of cholesterol–lowering Effect of Soy Protein and Isoflavones on Postmenopausal Women and Hypercholesterolemic Humans.
    112. An evidence-based guide to cholesterol–lowering guidelines
    113. An Immunomodulating Fatty Acid Analogue Targeting Mitochondria Exerts Anti-Atherosclerotic Effect beyond Plasma cholesterol–lowering Activity in apoE …
    114. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol–lowering properties
    115. An in vivo assessment of the cholesterol–lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults
    116. An innovative lipid-lowering approach to enhance attainment of low-density lipoprotein cholesterol goals
    117. An overview of trials of cholesterol lowering and risk of stroke
    118. An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low‐density lipoprotein cholesterol
    119. Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of …
    120. Analysis of plant sterol and stanol esters in cholesterol–lowering spreads and beverages using high-performance liquid chromatography− atmospheric pressure …
    121. Angiographic trials testing the efficacy of cholesterol lowering in reducing progression or inducing regression of coronary atherosclerosis
    122. Animal models: new cholesterol raising and lowering nutrients
    123. Anti-hyperlipidemia of garlic by reducing the level of total cholesterol and low-density lipoprotein: A meta-analysis
    124. Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
    125. Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-κB activity and lowering of cholesterol
    126. Anti-obesity and cholesterol–lowering effects of germinated brown rice in rats fed with high fat and cholesterol diets
    127. Anti-obesity and LDL-cholesterol lowering effects of silkworm hemolymph in C57BL/6N mice fed high fat diet
    128. Anti-obesity and lipid lowering effects of Cymodocea nodosa sulphated polysaccharide on high cholesterol-fed-rats
    129. Antiamnesic effect of petroleum ether extract of Murraya Koenigii (Linn) leaves involving possible Anticholinesterase and cholesterol lowering mechanism
    130. Antibacterial and cholesterol Reducing Lactic Acid Bacteria from Silk Worm(Bombyx mori) Gut Environment- A Review
    131. Antidiabetic and cholesterol lowering activities of the stem bark of Ficus bengalensis L.
    132. Antihyperglycemic, cholesterol–lowering and HDL-raising effects of cumin (Cuminum cyminum) seeds in type-2 diabetes
    133. Antihyperlipidemic therapies targeting PCSK9: Novel therapeutic agents for lowering low-density lipoprotein cholesterol
    134. Antihypertensive and cholesterol–lowering effects of a spread containing bioactive peptides IPP and VPP and plant sterols
    135. Antiobesity and cholesterol–lowering effects of bifidobacteria animalis DY-64 in rats fed a high-fat/high-cholesterol diet
    136. Antiobesity and cholesterol–lowering Effects of Dendropanax morbifera Water Extracts in Mouse 3T3-L1 Cells
    137. Antioxidant activity and lipid-lowering effect of essential oils extracted from Ocimum sanctum L. leaves in rats fed with a high cholesterol diet
    138. Antioxidant activity and the potential for cholesterol‐lowering of phenolic extract of Morus alba, Morus multicaulis, and Morus laevigata leaves from Yunnan (China)
    139. ANTIOXIDANT ACTIVITY, cholesterol lowering EFFECT AND CHEMICAL INVESTIGATION OF PO-SA (STEM)
    140. Antioxidant and cholesterol lowering properties of 2, 6-di-t-butyl-4-[(dimethylphenylsilyl) methyloxy] phenol and derivatives: a new class of anti-atherogenic …
    141. Antioxidant and cholesterol–lowering Effects of Lactic Acid Bacteria Isolated from Kelp Saccharina japonica Kimchi
    142. Antioxidant and cholesterol-reducing Properties of Enterococcus gallinarum m661 [J]
    143. Antioxidant and Lipid lowering Effects of Elaeocarpus Ganitrus in cholesterol Fed Rabbits
    144. Antioxidant, cholesterol reducing, immunomodulating and other health promoting properties of herbal enriched designer eggs
    145. Antioxidants and cholesterol-reducing agents with antiatherogenic activity contained in plant raw materials
    146. Antioxidative and cholesterol–lowering effects of lemon essential oil in hypercholesterolemia-induced rabbits
    147. Aortic vascular calcification: cholesterol lowering does not reduce progression in patients with familial hypercholesterolemia—or does it?
    148. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering.
    149. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study
    150. APOE4 genotype exerts greater benefit in lowering plasma cholesterol and apolipoprotein B than wild type (E3/E3), after replacement of dietary saturated fats with low …
    151. Apolipoprotein E mimetics and cholesterol–lowering properties
    152. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels
    153. Applicability of cholesterol–lowering primary prevention trials to a general population: the Framingham Heart Study
    154. Application of Actinomycetes in the Production of Pravastatin, a novel cholesterol–lowering agent (in Japanese with English abstract)
    155. Application of Bile Salt Hydrolase Enzyme in cholesterol lowering
    156. Appropriate use of cholesterol–lowering therapy
    157. ARBITER 2: targeting HDL to retard atherosclerosis progression: Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol (ARBITER) 2
    158. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol: a randomized trial comparing the effects of atorvastatin and …
    159. Are cholesterol treatment targets a deterrent to optimal lipid-lowering therapy?
    160. Are cholesterol–lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor?
    161. Are early clinical effects of cholesterol lowering mediated through effects on inflammation?
    162. Are oat products effective cholesterol–lowering agents?
    163. Are plant-based diets efficacious in lowering total serum cholesterol and low-density lipoprotein levels?
    164. Are we aggressive enough in lowering cholesterol?
    165. Aronia berry polyphenol consumption reduces plasma total and low-density lipoprotein cholesterol in former smokers without lowering biomarkers of inflammation and …
    166. Arterial Stiffness Interferes with LDL‐cholesterol lowering by Canola Oil in Persons with Mild Hypercholesterolemia
    167. ASGR1-a new target for lowering non-HDL cholesterol
    168. Assess the effectiveness of cocoa powder in reducing cholesterol level among the hypertensive clients at the rural area, Medavakkam, Chennai
    169. Assess the effectiveness of cocoa powder in reducing cholesterol levels among the Hypertensive clients at the rural area, Medavakkam, Chennai.
    170. Assessing heart disease risk in primary care: cholesterol lowering should be just one part of a multiple risk factor intervention
    171. Assessing possible hazards of reducing serum cholesterol
    172. Assessing the efficacy of cholesterol–lowering treatment.
    173. Assessing the genetic impacts of 144 candidate polymorphisms on the low-density lipoprotein cholesterol lowering efficacy of atorvastatin in Han Chinese
    174. Assessment of probiotic, antifungal and cholesterol lowering properties of Pediococcus pentosaceus KCC‐23 isolated from Italian ryegrass
    175. Assessment of the dietary intake in participants of the cholesterol lowering Intervention Program.
    176. Assessment of the longer-term effects of a dietary portfolio of cholesterol–lowering foods in hypercholesterolemia
    177. Association between calcific aortic stenosis and hypercholesterolemia: Is there a need for a randomized controlled trial of cholesterol‐lowering therapy?
    178. Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary …
    179. Association between low-density lipoprotein cholesterol–lowering genetic variants and risk of type 2 diabetes: a meta-analysis
    180. Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate …
    181. Association of genetically enhanced lipoprotein lipase–mediated lipolysis and low-density lipoprotein cholesterol–lowering alleles with risk of coronary disease and …
    182. Association of lowering low‐density lipoprotein cholesterol with contemporary lipid‐lowering therapies and risk of diabetes mellitus: a systematic review and meta …
    183. Association of the TNF-α-C-857T Polymorphism With Resistance to the cholesterol–lowering Effect of HMG-CoA Reductase Inhibitors in Type 2 Diabetic Subjects
    184. Atherosclerosis, acute coronary events, and cholesterol–lowering: a new paradigm
    185. Atherosclerosis/Coronary Heart Disease: Short-term cholesterol lowering Decreases Size and Severity of Perfusion Abnormalities by Positron Emission Tomography …
    186. Atorvastatin has cardiac safety at intensive cholesterol‐reducing protocols for long term, yet its cancer‐treatment doses with chemotherapy may cause cardiomyopathy …
    187. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE* 3-Leiden. CETP mice
    188. Atorvastatin more effective in reducing LDL cholesterol
    189. ATTENUATED RESPONSE OF LIPID PLAQUE TO cholesterol lowering THERAPY IN DIABETIC PATIENT: AN OPTICAL COHERENCE TOMOGRAPHY …
    190. Attitude changes of general practitioners towards lowering LDL cholesterol
    191. Automated outreach to increase primary adherence to cholesterol–lowering medications
    192. Azalanstat (RS-21607), a lanosterol 14α-demethylase inhibitor with cholesterol–lowering activity
    193. Bacterial production of the fungus‐derived cholesterol‐lowering agent mevinolin
    194. Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces
    195. Balance of unsaturated fatty acids is important to a cholesterol–lowering diet: comparison of mid-oleic sunflower oil and olive oil on cardiovascular disease risk factors
    196. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT–TIMI 22 (Pravastatin or Atorvastatin …
    197. Baseline low-density lipoprotein cholesterol predicts the hemoglobin A1c-lowering effect of dapagliflozin in Japanese patients with type 2 diabetes mellitus
    198. Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
    199. Beclobrate and eniclobrate hydrochloride, new diphenylmethane derivatives as agents for lowering cholesterol and triglyceride levels. Part I: Synthesis and …
    200. Behavioral implications of lowering cholesterol levels: a double-blind pilot study
    201. Bempedoic Acid CLEAR Serenity Study Results Published in the JAHA Demonstrated Significant LDL-cholesterol lowering and
    202. Bempedoic acid for lowering LDL cholesterol
    203. Bempedoic Acid: A Novel LDL cholesterol–lowering Agent
    204. Beneficial effect of cholesterol–lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients
    205. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study
    206. Beneficial effects of cholesterol–lowering therapy in hyperlipidemia patients-A six months report
    207. Beneficial effects of cholesterol–lowering therapy on the coronary endothelium in patients with coronary artery disease
    208. Beneficial effects of probiotic cholesterol–lowering strain of Enterococcus faecium WEFA23 from infants on diet-induced metabolic syndrome in rats
    209. Benefits and risks of lowering serum cholesterol
    210. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    211. Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol
    212. Benefits of lowering cholesterol in chronic kidney disease
    213. Benefits of lowering cholesterol in chronic kidney disease
    214. Benefits of lowering cholesterol in chronic kidney disease–Authors’ reply
    215. Benefits of reducing low density lipoprotein cholesterol concentrations to< 100 mg/dL
    216. Berberine Analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure− activity relationships, and cholesterol–lowering …
    217. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway
    218. Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome
    219. Beyond cholesterol–lowering effects of plant sterols: clinical and experimental evidence of anti-inflammatory properties
    220. Beyond the cholesterol–lowering effect of soy protein: a review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease
    221. Bezalip has been shown to be more effective than Clofibrate in reducing cholesterol, triglyceride, LDL ai VLDL and in raising the protective factor HDL1, 2
    222. Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver
    223. Bile tolerance, Bile Deconjugation and cholesterol reducing properties of Lactobacillus strains isolated from traditional fermented foods
    224. Biochemical basis for a cholesterol–lowering activity of 2-[2′-(1′, 3′-dioxolane)]-2-methyl-4-(2′-oxo-1′-pyrrolidinyl)-6-nitro-2H-1-benzopyran (SKP-450), a novel …
    225. Biochemical characterization of cholesterol-reducing Eubacterium.
    226. Biological evaluation of biscuits prepared from citrus peels as a lowering cholesterol
    227. Biologics inch toward cholesterol–lowering market
    228. Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
    229. Blepharoptosis and cholesterol–lowering Medications: A Retrospective Study
    230. Blockage of hydroxyl group partially abolishes the cholesterol–lowering activity of β-sitosterol
    231. Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers.
    232. Blood cholesterol lowering effect of adenantherapavonina seed extract on atherogenic diet induced hyperlipidemia in rats
    233. Blood lipids and stroke: what more can we do besides reducing low-density lipoprotein cholesterol?
    234. Blood pressure and cholesterol–lowering efficacy of a fixed-dose combination with irbesartan and atorvastatin in patients with hypertension and …
    235. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
    236. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence
    237. Blood sugar and total cholesterol lowering effect of Glycine soja (Sieb and Zucc.), Mucuna pruriens (DC) and Dolichos biflorus (Linn.) seed diets in normal fasting …
    238. Blood-pressure and cholesterol lowering in persons without cardiovascular disease
    239. Blood-Pressure and cholesterol lowering in the HOPE-3 Trial.
    240. Blood-pressure and cholesterol lowering in the HOPE-3 Trial.
    241. Body mass index impacts the choice of lipid‐lowering treatment with no correlation to blood cholesterol–Findings from 52 916 patients in the Dyslipidemia …
    242. Body-weight-loss and cholesterol–lowering effects of Cheonggukjang (a fermented soybean paste) given to rats fed a high-fat/high-cholesterol diet
    243. Brain cholesterol x: effect of scheduling on the sterol lowering capability of methylphenidate (Ritalin).
    244. Breast cancer; role of tamoxifen as selective estrogen receptor modulator in preventing bone loss, reducing serum cholesterol and activity of liver enzymes in patients …
    245. But will lowering cholesterol raise cancer rates?
    246. Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein
    247. Calcium supplementation increases circulating cholesterol by reducing its catabolism via GPER and TRPC1-dependent pathway in estrogen deficient women
    248. Can a cholesterol–lowering diet cause gallstones?
    249. Can any agreement be reached on cholesterol lowering?
    250. Can cholesterol–lowering be harmful?
    251. Cancer among men on cholesterol–lowering diets: experience from five clinical trials
    252. Candidate‐Gene Study of Functional Polymorphisms in SLCO1B1 and CYP3A4/5 and the cholesterol‐lowering Response to Simvastatin
    253. Carboxymethylation of polysaccharide from Morchella angusticepes Peck enhances its cholesterol–lowering activity in rats
    254. Cardiovascular Benefit of cholesterol–lowering Therapy
    255. Cardiovascular benefit of cholesterol–lowering therapy: does improved endothelial vasodilator function matter?
    256. Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: a population …
    257. Cardiovascular mortality after intensive LDL-cholesterol lowering: Does baseline LDL-cholesterol really matter?
    258. Cardiovascular outcomes associated with lowering low-density lipoprotein cholesterol in rheumatoid arthritis and matched nonrheumatoid arthritis
    259. Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterol lowering
    260. Cerivastatin induces carotid artery plaque stabilization independently of cholesterol lowering in patients with hypercholesterolaemia
    261. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure-and cholesterol–lowering effects
    262. Challenges to implementing expanded team models: lessons from a centralised nurse-led cholesterol–lowering programme
    263. Changes in cholesterol–lowering medications use over a decade in community-dwelling older adults
    264. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men
    265. Changes in vitamin and mineral intakes and serum concentrations among free-living men on cholesterol–lowering diets: the dietary Alternatives Study
    266. Characterisation of an extract and fractions of Azadirachta indica flower on cholesterol lowering property and intestinal motility
    267. Characterisation of Lactobacillus fermentum SM‐7 isolated from koumiss, a potential probiotic bacterium with cholesterol‐lowering effects
    268. Characterisation of non human origin probiotic Lactobacillus plantarum with cholesterol–lowering property
    269. Characteristics associated with compliance to cholesterol lowering eating patterns
    270. Characteristics of cholesterol–lowering Lactobacillus casei subsp. casei strain GL-03 isolated from cheese
    271. Characteristics of growth and the cholesterol-reducing ability in meat of native lactic acid bacteria
    272. Characterization and application of a novel cholesterol-reducing anaerobe, Eubacterium coprostanoligenes ATCC 51222
    273. CHARACTERIZATION OF A cholesterol-REDUCING ANAEROBE
    274. Characterization of Eubacterium coprostanoligenes sp. nov., a cholesterol-reducing anaerobe
    275. Characterization of juice fermented with Lactobacillus plantarum EM and its cholesterol‐lowering effects on rats fed a high‐fat and high‐cholesterol diet
    276. Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: A potential probiotic bacterium with cholesterol–lowering effects
    277. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol–lowering effects
    278. Characterization of low‐density lipoprotein cholesterol‐lowering efficacy for atorvastatin in a population‐based DNA biorepository
    279. Characterization of starter kimchi fermented with Leuconostoc kimchii GJ2 and its cholesterol‐lowering effects in rats fed a high‐fat and high‐cholesterol diet
    280. Characterization of the cholesterol-reducing activity in a cell-free supernatant of Lactobacillus acidophilus ATCC 43121
    281. Chemerin Inhibiting ABCAl Expression and Reducing cholesterol Efflux in THP-1-derived Macrophage Foam Cells Mediated by NF-κB Pathway
    282. Chemical and microbiological considerations of phytosterols and their relative efficacies in functional foods for the lowering of serum cholesterol levels in humans: A …
    283. Chemical composition of soybean oil extracted from hypocotyle-enriched soybean raw material and its cholesterol lowering effects in rats
    284. Chemoenzymatic synthesis of statine side chain building blocks and application in the total synthesis of the cholesterol–lowering compound solistatin
    285. Chimeric apolipoproteins as novel plasma cholesterol lowering agents (1002.2)
    286. Chitosan, cholesterol lowering, and caloric loss
    287. Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up‐regulating the gene expression of PPAR‐α in hypercholesterolemic rats …
    288. Choice of the optimal medium for the growth of cholesterol-reducing Lactobacillus casei WB
    289. Cholestanol: a serum marker to guide LDL cholesterol–lowering therapy
    290. cholesterol (Blood lipid) lowering potential of Rosuvastatin chitosan nanoparticles for atherosclerosis: Preclinical study in rabbit model
    291. cholesterol absorption inhibition: a strategy for cholesterol–lowering therapy.
    292. cholesterol absorption inhibition: filling an unmet need in lipid-lowering management
    293. cholesterol and Cognition: Rationale for the AD cholesterol‐lowering Treatment Trial and Sex‐Related Differences in β‐Amyloid Accumulation in the Brains of …
    294. cholesterol and fat lowering with hydrophobic polysaccharide derivatives
    295. cholesterol and fat lowering with hydrophobic polysaccharide derivatives
    296. cholesterol and strokes: cholesterol lowering is indicated for strokes due to carotid atheroma
    297. cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats
    298. cholesterol and Visceral Fat lowering Effects of Combined Lactic Acid Bacteria (Lactobacillus casei WK3, Enterococcus faecium WK5, Bifidobacterium longum WK9 …
    299. cholesterol depletion by mβcd enhances cell membrane tension and its variations-reducing integrity
    300. cholesterol Depletion Impairs Vascular Reactivity to Endothelin-1 by Reducing Store-Operated Ca2+ Entry Dependent on TRPC1
    301. cholesterol depletion uncouples β-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle
    302. cholesterol efflux from bovine sperm: II. Effect of reducing sperm cholesterol on penetration of zona‐free hamster and in vitro matured bovine ova
    303. cholesterol efflux from bovine sperm. I. Induction of the acrosome reaction with lysophosphatidylcholine after reducing sperm cholesterol
    304. cholesterol ester transfer protein polymorphism rs5882 is associated with triglyceride-lowering in response to plant sterol consumption
    305. cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia …
    306. cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment
    307. cholesterol lowering
    308. cholesterol lowering a practical guide to therapy
    309. cholesterol lowering action and antioxidant status improving efficacy of noodles made from unmarketable oak mushroom (Lentinus edodes) in high cholesterol fed …
    310. cholesterol lowering action of HOE 402 in the normolipidemic and hypercholesterolemic golden Syrian hamster
    311. cholesterol lowering activity of formulated green caviar (Caulerpa lentillifera J. Agardh., Caulerpaceae) seaweed extract tablet in hypercholesterolemia-induced …
    312. cholesterol lowering activity of mango ginger (Curcuma amada Roxb.) in induced hypercholesterolemic rats
    313. cholesterol lowering activity of ropy fermented milk
    314. cholesterol lowering activity of soy‐derived glyceollins in golden hamster model
    315. cholesterol lowering activity of the aqueous fruit extract of Trichosanthes dioica Roxb. in normal and streptozotocin diabetic rats
    316. cholesterol lowering After Heart Transplantation is Associated with a Lower Incidence of Transplant Coronary Artery Disease.
    317. cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland
    318. cholesterol lowering and antioxidant potential of probiotic bacteria isolated from locally fermented milk product kalarei
    319. cholesterol lowering and Antioxidative Effect of Pregerminated Brown Rice in Hypercholesterolemic Rats
    320. cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment
    321. cholesterol lowering and cerebrospinal fluid neurotransmitters: Increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin …
    322. cholesterol lowering and coronary artery disease: mechanisms of risk reduction
    323. cholesterol lowering and Coronary Revascularization: Finally a Marriage to Sustain?
    324. cholesterol lowering and emotional distress: Current status and future directions.
    325. cholesterol lowering and endothelial function
    326. cholesterol lowering and ezetimibe
    327. cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
    328. cholesterol lowering and life expectancy: a critical evaluation
    329. cholesterol lowering and morbidity and mortality.
    330. cholesterol lowering and mortality: the importance of considering initial level of risk.
    331. cholesterol lowering and mortality: time for a new paradigm?
    332. cholesterol lowering and prevention of CHD
    333. cholesterol lowering and Prevention of Stroke: An Overview
    334. cholesterol lowering and secondary prevention of CHD–the evidence of benefit is unequivocal
    335. cholesterol lowering and the reduction of CHD incidence and total mortality: results from a meta-analysis of randomized trials
    336. cholesterol lowering and the reduction of coronary heart disease risk
    337. cholesterol lowering and the risk of coronary heart disease
    338. cholesterol lowering and the risk of stroke
    339. cholesterol lowering and the risk of stroke-Reply
    340. cholesterol lowering and the use of healthcare resources: results of the Scandinavian Simvastatin Survival Study
    341. cholesterol lowering and the vessel wall: new insights and future perspectives
    342. cholesterol lowering and vascular protective effects of ethanolic extract of dried fruit of Crataegus pinnatifida, hawthorn (Shan Zha), in diet-induced …
    343. cholesterol lowering as a treatment for established coronary heart disease.
    344. cholesterol lowering Atherosclerosis Study (CLAS)
    345. cholesterol lowering Atherosclerosis Study (CLAS)
    346. cholesterol lowering attenuates pressure overload-induced heart failure in mice with mild hypercholesterolemia
    347. cholesterol lowering benefits of soy and linseed enriched foods
    348. cholesterol lowering by a-linolenic acid
    349. cholesterol lowering by atorvastatin parallels rapid changes in intima-media thickness and diamter of carotid arteries
    350. cholesterol lowering by Citrus
    351. cholesterol lowering by diet: what can be achieved?
    352. cholesterol lowering by Pediococcus acidilactici LAB4 and Lactobacillus plantarum LAB12 in adult zebrafish is associated with improved memory and involves an …
    353. cholesterol lowering Capability of some Lactobacillus Strains and its Effect on Mice Fed a High cholesterol diet
    354. cholesterol lowering Capacity of Lactic Acid Bacteria Isolated from Fermented Tapai
    355. cholesterol lowering diets and coronary heart disease: Advice should now be to increase intake of vegetable oils and fish
    356. cholesterol lowering diets and coronary heart disease: diet alone substantially reduces cholesterol in hypercholesterolaemia
    357. cholesterol lowering diets and coronary heart disease. dietary advice should focus on promoting antioxidants and the right sort of fats.
    358. cholesterol lowering does have a role in secondary prevention.
    359. cholesterol lowering effect in the gall bladder of dogs by a standardized infusion of Herniaria hirsuta L.
    360. cholesterol lowering effect in the gall bladder of dogs by Herniaria hirsuta
    361. cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemia
    362. cholesterol lowering effect of Aporosa lindleyana in male Wistar rats.
    363. cholesterol lowering effect of cashew leaf (Anacardium occidentale) extract on egg yolk induced hypercholesterolaemic rabbits
    364. cholesterol lowering EFFECT OF CHITOSAN NANOPARTICLES USING PARIJOTO FRUITS EXTRACT
    365. cholesterol lowering effect of Citrus paradisi (Grape fruit) peel extract in hypercholestrolemic patients in an urban community: A randomized control trial.
    366. cholesterol lowering effect of Cnidoscolous aconitifolius leave extracts in egg yolk induced hypercholesterolemia in rabbit
    367. cholesterol lowering Effect of Colchicine.
    368. cholesterol lowering effect of dietary weight loss and orlistat treatment–efficacy and limitations
    369. cholesterol lowering effect of dietary yeast and yeast fractions
    370. cholesterol lowering effect of Enterococcus faecium ID9201 isolated from breast milk-fed Korean infant
    371. cholesterol lowering Effect of Ethanol Extracts of Salted and Fermented Small Shrimp in Rats Administered a High Fat diet
    372. cholesterol lowering effect of guava leaves (Psidium guajava) extract on egg yolk induced hypercholestero-laemic rabbits
    373. cholesterol lowering effect of jackbean (Canavalia ensiformis) seed protein.
    374. cholesterol lowering effect of lactic acid bacteria isolated from the human intestine.
    375. cholesterol lowering effect of Lactobacillus plantarum isolated from human feces
    376. cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial
    377. cholesterol lowering effect of neomycin and N-methylated neomycin in germfree chicks.
    378. cholesterol lowering effect of plant stanol ester yoghurt drinks with added camelina oil
    379. cholesterol lowering effect of SG-GN3, the extract of salted and fermented small shrimps, Acetes japonicus, in Triton WR-1339 or high cholesterol–diet induced …
    380. cholesterol lowering Effect of Simvastatin in Patients with Normal and Impaired Renal Function
    381. cholesterol lowering effect of spirulina.
    382. cholesterol lowering effect of subchronic inhalation particulate matter 10 coal dust on rats
    383. cholesterol lowering effect of sulfur-containing amino acids added to a soybean protein diet in rats
    384. cholesterol lowering effect of Tamarind (Tamarindus indica)
    385. cholesterol lowering effect of the methanol insoluble materials from the quinoa seed pericarp
    386. cholesterol lowering effect of the recombinant α’E peptide from 7S soy globulin in cholesterol‐fed rats upon chronic treatment
    387. cholesterol lowering effects of a choleretic phloracetophenone in hypercholesterolemic hamsters
    388. cholesterol lowering effects of acacia nilotica subalata in normal and type 2 diabetic male rats
    389. cholesterol lowering Effects of Milk with Added Phytosterols
    390. cholesterol lowering effects of milk with added plant sterols
    391. cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann–Pick type C disease-like HepG2 cells
    392. cholesterol lowering effects of nuts compared with a Canola oil enriched cereal of similar fat composition
    393. cholesterol lowering effects of red koji
    394. cholesterol lowering effects of rhubarb stalk fiber in hypercholesterolemic men.
    395. cholesterol lowering effects of simvastatin in patients with non-insulin dependent diabetes mellitus
    396. cholesterol lowering efficacy of plant stanol ester in a new type of product matrix, a chewable dietary supplement
    397. cholesterol lowering efficacy of plant sterols: mechanisms of action.
    398. cholesterol lowering Efficacy of Simvastatin at Doses of 80 and 160 mg/d in a new low systemic exposure formulation
    399. cholesterol lowering for all: a closer look
    400. cholesterol lowering for secondary prevention of coronary artery disease: Assessment of screening and treatment practices in Hamilton
    401. cholesterol lowering for the prevention of stroke
    402. cholesterol lowering guidelines: from whence we came and where we are now
    403. cholesterol lowering Herbal Program
    404. cholesterol lowering improves endothelial function
    405. cholesterol lowering in 2015: still answering questions about how and in whom
    406. cholesterol lowering in atherosclerosis
    407. cholesterol lowering in Cancer Prevention and Therapy
    408. cholesterol lowering in intermediate-risk persons without cardiovascular disease
    409. cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E.
    410. cholesterol lowering in older patients